期刊文献+

厄贝沙坦/氢氯噻嗪治疗原发性高血压的研究 被引量:1

Study on Irbesartan and hydrochlorothiazide for primary hypertension
下载PDF
导出
摘要 目的评价厄贝沙坦/氢氯噻嗪治疗原发性高血压的疗效及对左心功能的影响。方法50例原发性高血压患者均服用厄贝沙坦/氢氯噻嗪片1片,1次/d,观察服药前后血压、左心功能、血尿酸、电解质等指标变化及不良反应。结果患者血压明显下降(P<0.05),左心舒张功能及心脏整体功能得到改善,血生化指标无明显变化,无不良反应。结论厄贝沙坦/氢氯噻嗪片是治疗原发性高血压的有效药物,疗效好,不良反应少,患者依从性好。 Objective It is to evaluate the curative effect of Irbesartan and hydrochlorothiazide on primary hypertension and left ventricular function. Methods 50 cases of patients with primary hypertension were given one tablet of Irbesartan and hydrochlorothiazide once every day. The changes of indexes such as lood pressure, left ventricular function, serum uric acid and electrolyte and adverse reactions were observed before and after treatment. Results Blood pressure was brought down obviously(P〈 0.05) in the patients, left ventricular diastolic function and the whole function of heart were improved( P 〈 0. 05 ). There was no obvious change of blood biochemical indicators (P 〉 0.05) and rare adverse reaction. Conclusion Irhesartan and hydrochlorothiazide tablet is an effective medicine for primary hypertension, with good effect and compliance, less side effect.
出处 《现代中西医结合杂志》 CAS 2008年第34期5262-5263,5266,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 厄贝沙坦/氢氯噻嗪 高血压 超声心动图 Irbesartan and hydrochlorothiazide hypertension echocardiogram
  • 相关文献

参考文献12

  • 1蒋雄京,李卫,马林茂,孔灵芝,金水高,刘力生.医院门诊就诊人群高血压相关知识及其对高血压防治的影响[J].中华流行病学杂志,2002,23(4):269-272. 被引量:40
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3张丽香,张烈云,郭宪清.厄贝沙坦/氢氯噻嗪复方片剂治疗轻中度原发性高血压疗效观察[J].现代中西医结合杂志,2008,17(19):2917-2917. 被引量:6
  • 4Howe P, Phillips P, Saini R, et al. The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24 - hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group [ J ]. Clin Exp Hypertens, 1999,21 : 1373 - 1396
  • 5孙宁玲,荆珊,陈捷.厄贝沙坦/氢氯噻嗪复方片剂治疗中国高血压病患者的达标率分析[J].中华心血管病杂志,2005,33(7):618-621. 被引量:108
  • 6Garcia MJ,Rodriguez L,Ares M, et al. Myocardial wall velocity assessment by pulsed Doppler tissue imaging: Characteristic findings in normal subjects[J ]. Am Heart J, 1996,132:648
  • 7Derumeaux G,Ovize M, Loufoua J, et al. Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging:Characterization of normal, ischemic, and stunned myocardium[ J]. Circulation, 2000,101 : 1390
  • 8Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value[J ]. J Am Co]l Cardial,2003,41:820
  • 9Waggoner AD, Bierig SM. Tissue Doppler imaging:A useful ec-hocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function [ J ]. J Am Soc Echocardiogr, 2001,14:1143
  • 10Kukulski T, Jamal F, D' Hooge J, et al. Acute changes in systolic and diastolic events during clinical coronary angioplasty:A comparison of regional velocity,strain rate,and strain measurement[J]. J AM Soc Echocardiogr, 2002,15 : 1

二级参考文献17

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2孙宁玲,荆珊,陈捷.厄贝沙坦/氢氯噻嗪复方片剂治疗中国高血压病患者的达标率分析[J].中华心血管病杂志,2005,33(7):618-621. 被引量:108
  • 3Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension, 2003,42:239-246.
  • 4Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet,2000,29;356:366-372.
  • 5Howe P, Phillips P, Saini R, et al.The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group. Clin Exp Hypertens. 1999,21:1373-1396.
  • 6中国高血压防治指南起草委员会.1999中国高血压防治指南[J].高血压杂志,2000,8:94-112.
  • 7European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens,2003,21:1011-1053.
  • 8Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.Lancet. 1998,351:1755-1762.
  • 9Wollert KC, Drexler H. The rennin-angiotensin system and experimental heart failure [J]. Cardiovasc Res, 1999, 4399: 838-849.
  • 10Diedrichs H, Chi M, Boelck B, et al. Increased regulatory activity of the calcineruin/NFAT pathway in human heart failure [J]. Eur J Heart Fail,2004,6:3-9.

共引文献2743

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部